- 专利标题: Proteasome activity enhancing compounds
-
申请号: US16902019申请日: 2020-06-15
-
公开(公告)号: US11242361B2公开(公告)日: 2022-02-08
- 发明人: Matthew Cullen , Sheila Hauck , Bolin Geng , Megan Foley , Cecilia M. Bastos , Benito Munoz , Markus Haeberlein , Bradley Tait
- 申请人: Proteostasis Therapeutics, Inc.
- 申请人地址: US MA Boston
- 专利权人: Proteostasis Therapeutics, Inc.
- 当前专利权人: Proteostasis Therapeutics, Inc.
- 当前专利权人地址: US MA Boston
- 代理机构: Armstrong Teasdale LLP
- 主分类号: C07F7/18
- IPC分类号: C07F7/18 ; C07D401/14 ; C07D401/06 ; C07D403/06 ; C07D471/04 ; C07D209/12 ; C07D209/14 ; C07D417/14 ; C07D519/00 ; C07B59/00
摘要:
The present invention is directed to compounds having the Formula (I), (II), (III), (IV), and (V), compositions thereof, and methods for the treatment of a condition associated with a dysfunction in proteostasis.
公开/授权文献
- US20200308198A1 PROTEASOME ACTIVITY ENHANCING COMPOUNDS 公开/授权日:2020-10-01
信息查询